Talk Title to be Announced
Courtney H. Lias, PhD
Acting Director, OHT7: Office of in vitro Diagnostic Devices,
United States Food and Drug Administration (FDA)
PLENARY PANEL: Laboratory-Developed Tests:
Proposed Rule, Reclassification Activities, Potential Impact, and Path Forward
![B. Melina Cimler](/images/librariesprovider44/home/24/cimler.png?sfvrsn=c35be0b8_1)
MODERATOR:
B. Melina Cimler, PhD, CEO & Founder, PandiaDx LLC
![Stefan Burde, PhD](/images/librariesprovider44/home/24/burde.png?sfvrsn=2f222e9b_1)
PANELISTS:
Stefan Burde, PhD, Director, Global Strategic Business Development, TÜV SÜD America, Inc.
![Girish Putcha](/images/librariesprovider44/home/24/putcha.png?sfvrsn=d1347e4c_1)
Girish Putcha, MD, PhD, Principal & Founder, Precision Medicine & Diagnostics
![Lakshman Ramamurthy, PhD](/images/librariesprovider44/home/24/lakshman_bluecircle.png?sfvrsn=d23c6601_1)
Lakshman Ramamurthy, PhD, Vice President Regulatory Affairs, GRAIL
![Laurie Anna Scrimenti](/images/librariesprovider44/home/24/scrimenti.png?sfvrsn=6620cf66_1)
Anna Scrimenti, Associate Director, Public Policy & Advocacy, Association for Molecular Pathology